The global Liver Cancer Diagnostic Market scope was projected at US$ 8.25 billion in 2017. It is expected to reach US$ 15.4 billion by 2025 with a CAGR of 8.1% during the forecast period. Liver cancer diagnostic refers to advanced medical techniques used in healthcare facilities to confirm presence of unwanted cell growth in human body. Continuous exposure to carcinogenic substances and changes in deoxyribonucleic acid (DNA) can damage tumor suppressor genes. Permanent damage to suppressor genes can lead to growth of abnormal cells affected organ. Hepatocellular Carcinoma (HCC) is considered as the most common form of primary liver cancer in adults.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/liver-cancer-diagnostic-market/request-sample
Market Synopsis of Liver Cancer Diagnostic Market:
Growing prevalence of liver
cancer owing to unhealthy eating and drinking habits is anticipated to propel
liver cancer diagnostics market growth. Regular consumption of spicy or
unhygienic food and alcohol can damage liver. Growing awareness among people regarding
importance of early diagnosis of the disease is expected to impel liver cancer
diagnostic industry growth. Detection of problem at early stage is likely to
increase possibilities of cure through chemotherapy or other effective
treatments. Moreover, advent of multiple screening procedures that are helping
healthcare professionals to detect the problem at initial stage will drive the
liver cancer diagnostics industry over the forecast period. Available
laboratory tests for HCC include urinalysis, sputum cytology,
immunophenotyping, and urine cytology. These tests allow healthcare
professionals to detect abnormalities in tissue structure and cells inside
humans.
To cater to rising demand for
early diagnosis, companies are investing in R&D to develop effective
therapeutic treatments. For instance, in September 2019, Laboratory for
Advanced Medicine (LAM) has received breakthrough device designation from food
and drug administration (FDA). The organization has received this badge for
test to detect liver cancer. The test can detect the problem at early stage
with high sensitivity and specificity. In addition, the test offers low false
negative and false positive rate.
Screening Type Insights:
Based on screening type, the
liver cancer diagnostic market can be segregated into laboratory tests,
imaging, endoscopy, biopsy, and others. Laboratory tests segment is anticipated
to hold largest market share over the forecast period. These tests are further
segmented into biomarkers and blood tests. Such diagnostic techniques allow
healthcare professionals to confirm presence of cancerous cells in human body.
Imaging tests allow doctors to take clear images of internal organs to confirm
presence of tumor. Such tests include magnetic resonance imaging (MRI), computed
tomography (CT) scan, ultrasound, x-ray, and other radiographic tests.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/liver-cancer-diagnostic-market
Table of Contents:-
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Liver Cancer Diagnostic:
Market Variables, Trends & Scope
Chapter 4 Liver Cancer Diagnostic:
Product Estimates & Trend Analysis
Chapter 5 Liver Cancer Diagnostic:
Application Estimates & Trend Analysis
Chapter 6 Liver Cancer Diagnostic:
End-use Estimates & Trend Analysis
Chapter 7 Liver Cancer Diagnostic:
Industrial End-use Estimates & Trend Analysis
Chapter 8 Liver Cancer Diagnostic:
Regional Estimates & Trend Analysis
Chapter 9 Competitive Landscape
Chapter 10 Liver Cancer
Diagnostic: Manufacturers Company Profiles
Get in touch
At Million Insights, we work with
the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
No comments:
Post a Comment